AMED logo

AMED

Asia, Tokyo, Japan, Tokyo

Description

Japan Agency for Medical Research and Development is an independent japanese medical research and development organization.

Investor Profile

AMED has backed more than 6 startups, with 5 new investments in the last 12 months alone. The firm has led 5 rounds, about 83% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Corporate Round rounds (top funding stages).
  • Majority of deals are located in Japan, United States.
  • Strong thematic focus on Health Care, Biotechnology, Therapeutics.
  • Led 5 rounds in the past year.

Stage Focus

  • Grant (83%)
  • Corporate Round (17%)

Country Focus

  • Japan (50%)
  • United States (50%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Business Information Systems
  • Document Management
  • Information Services
  • Manufacturing
  • Alternative Medicine
  • Clinical Trials
  • Outpatient Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AMED frequently co-invest with?

Hamari Chemicals
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Chiyoda Corporation
Asia, Kanagawa, Japan, Yokohama
Co-Investments: 1
Kishida Japan
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1
Nagase & Co
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Nakamura Choukou
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Microwave Chemical
Asia, Osaka, Japan, Suita
Co-Investments: 1
Mitsubishi Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by AMED?

AvenCell

Watertown, Massachusetts, United States

Based on our deep science and focused on patients in need.

Health Care
GrantJun 30, 2025
Amount Raised: $40,000,000
RevolKa

Sendai, Miyagi, Japan

RevolKa is a biotechnology firm that manufactures bio-products pharmaceuticals intended to serve the healthcare sector.

BiotechnologyHealth CarePharmaceutical
GrantJun 30, 2025
Amount Raised: $374,558
Rakuten Medical

San Diego, California, United States

Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox™ platform.

BiotechnologyHealth CareMedicalService IndustryTherapeutics
GrantJun 4, 2025
RegCell

Osaka, Osaka, Japan

RegCell is a novel therapeutics company.

Alternative MedicineClinical TrialsOutpatient Care
GrantMar 18, 2025
Amount Raised: $37,300,000
Shinobi Therapeutics

South San Francisco, California, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

BiotechnologyHealth CareTherapeutics
GrantAug 6, 2024
Amount Raised: $59,000,000
PeptiStar

Settsu, Osaka, Japan

PeptiStar continually strives to develop novel manufacturing technologies to address needs in every stage of the peptide value chain.

Business Information SystemsDocument ManagementInformation ServicesManufacturing
Corporate RoundApr 18, 2018
Amount Raised: $186,286,291